DENALI THERAPEUTICS INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.75 USD | +2.33% |
|
+17.21% | -7.97% |
| 08/05 | Stifel Adjusts Price Target on Denali Therapeutics to $22 From $26, Maintains Hold Rating | MT |
| 08/05 | Wedbush Adjusts Denali Therapeutics' Price Target to $30 From $31, Keeps Outperform Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| DENALI THERAPEUTICS INC. | Bio Therapeutic Drugs | +2.33% | +17.21% | -7.97% | -29.36% | -3.66% | 2.82B |  |  |  |
Technical Rankings Surperformance
- Stock Market
- Equities
- DNLI Stock
- Charts Denali Therapeutics Inc.
- Comparison Chart